Studies have demonstrated that serum NT-proBNP appears to be a good screening tool in BPD-associated pulmonary hypertension (12), and Blanco et.al demonstrated the NT pro-BNP of 5–10 days after birth may identify preterm infants with high risk of BPD (26). The gene discussed is NPPB; the disease is pulmonary arterial hypertension.